AUTOIMMUNE INJURY OF SQUAMOUS EPITHELIUM BY PEMPHIGUS AUTOANTIBODIES

The term pemphigus refers to a group of bullous diseases that are characterized by the presence of both intraepidermal blister formation and autoantibodies specific for epithelial cells (Lever, 1965). Pemphigus vulgaris, the commonest form, is a potentially lethal disease in which the blister occurs just above the basal cell layer. Pemphigus vegetans is an uncommon variant in which vegetating lesions are predominantly localized to flexural areas. Pemphigus fohaceus is a less serious disorder in which the blister is very superficial, occurring just below the stratum corneum. Brazilian pemphigus foliaceus (Fogo Selvagem) is a form of pemphigus foliaceus that occurs in an endemic fashion in Brazil. Pemphigus erythematosus (the Senear-Usher syndrome) is a clinical syndrome in which pemphigus foliaceus occurs in a patient with the clinical and serological features of lupus erythematosus (Senear & Usher, 1926). All forms of pemphigus are characterized by epidermal cell-cell detachment (acantholysis) leading to intraepidermal vesicle formation, and the presence of IgG antibodies directed against antigenic determinants present on the cell surfaces of differentiating keratinocytes (Beutner & Jordon, 1964). The underlying mechanisms which trigger this autoantibody formation are essentially unknown. The key problem that needs to be resolved is whether there is a breakdown in the self-tolerance of an unaltered antigen (the pemphigus antigen), or whether there is a change in the antigenicity of the antigen itself. There do appear to be genetic factors which predispose to the development of the disease. Although pemphigus vulgaris is found in all ethnic and racial groups, it has a higher incidence in Jews, and is associated with an increased prevalence of the HLA-DRw4 phenotype (Brautbar et al., 1980; Park, Terasaki & Ahmed, i979)Pemphigus has been associated with autoimmune disorders such as lupus erythematosus, rheumatoid arthritis, myasthenia gravis, pernicious anaemia, Hashimoto's thyroiditis and with benign thymomas (Diaz, Glamb & Silva, 1980; Maize, Green & Provost, 1982). Usually the course of pemphigus is not affected by the presence of these disorders. Pemphigus has also been associated with various malignancies, but the incidence of malignancy is not high, and temporal relationships are rare. Recently, penicillamine has been implicated as a potential causative factor in the induction of pemphigus foliaceus in some patients (Degos et al., 1969; Tan & Rowell, 1976). It has been estimated that pemphigus foliaceus will occur in about 7"^ of patients receiving long-term penicillamine therapy (Marsden et al., 1976), which makes the association seem more than fortuitous.

[1]  H. Cohen,et al.  HLA-DRw4 in pemphigus vulgaris patients in Israel. , 2008, Tissue antigens.

[2]  K. Wuepper,et al.  Isolation and purification of a pemphigus vulgaris antigen from human epidermis. , 1984, The Journal of clinical investigation.

[3]  J. Voorhees,et al.  Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. , 1983, The Journal of investigative dermatology.

[4]  J. Roujeau,et al.  Plasma exchange in pemphigus. Uncontrolled study of ten patients. , 1983, Archives of dermatology.

[5]  J. Maize,et al.  Pemphigus foliaceus: a case with serologic features of Senear-Usher syndrome and other autoimmune abnormalities. , 1982, Journal of the American Academy of Dermatology.

[6]  J. Voorhees,et al.  Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. , 1982, The New England journal of medicine.

[7]  J. S. Storer,et al.  Neonatal pemphigus vulgaris. , 1982, Journal of the American Academy of Dermatology.

[8]  B. Moncada,et al.  Neonatal pemphigus vulgaris: role of passively transferred pemphigus antibodies , 1982, The British journal of dermatology.

[9]  H. Ogawa,et al.  The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. , 1981, The Journal of investigative dermatology.

[10]  D. Swanson,et al.  Pemphigus vulgaris and plasma exchange: clinical and serologic studies. , 1981, Journal of the American Academy of Dermatology.

[11]  R. Fitzpatrick,et al.  The correlation of disease activity and antibody titers in pemphigus. , 1980, Archives of dermatology.

[12]  R. Papay,et al.  Appearance of "pemphigus acantholysis factor" in human skin cultured with pemphigus antibody. , 1979, The Journal of investigative dermatology.

[13]  P. Terasaki,et al.  HLA-DRW4 IN 91% OF JEWISH PEMPHIGUS VULGARIS PATIENTS , 1979, The Lancet.

[14]  R. Auerbach,et al.  Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris. , 1979, Archives of dermatology.

[15]  L. Diaz,et al.  Phylogenetic studies with pemphigus and pemphigoid antibodies. , 1978, Acta dermato-venereologica.

[16]  C. Marcelo,et al.  Pemphigoid and pemphigus antigens in cultured epidermal cells , 1978, The British journal of dermatology.

[17]  R. Marsden,et al.  Pemphigus foliaceus induced by penicillamine. , 1976, British medical journal.

[18]  J. Schiltz,et al.  Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. , 1976, The Journal of investigative dermatology.

[19]  N. Rowell,et al.  Pemphigus‐like syndrome induced by D‐penicillamine , 1976, The British journal of dermatology.

[20]  R. Jordon,et al.  Pemphigus antibodies: their role in disease. , 1971, The Journal of investigative dermatology.

[21]  J. Overton,et al.  The fat of desmosomes in trypsinized tissue. , 1968, The Journal of experimental zoology.

[22]  E. Beutner,et al.  AUTOANTIBODIES IN PEMPHIGUS VULGARIS: RESPONSE TO AN INTERCELLULAR SUBSTANCE OF EPIDERMIS. , 1965, JAMA.

[23]  E. Beutner,et al.  Demonstration of Skin Antibodies in Sera of Pemphigus Vulgaris Patients by Indirect Immunofluorescent Staining.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[24]  K. Terplán,et al.  Chronic thyroiditis and autoimmunization. , 1957, Journal of the American Medical Association.

[25]  F. Senear,et al.  AN UNUSUAL TYPE OF PEMPHIGUS: COMBINING FEATURES OF LUPUS ERYTHEMATOSUS , 1926 .

[26]  L. Parish,et al.  Brazilian Pemphigus Foliaceous , 1984 .

[27]  G. Lazarus,et al.  Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Revuz,et al.  Pemphigus chez un malade traité par pénicillamine pour maladie de Wilson. , 1969 .

[29]  H. Hatano,et al.  [Pemphigus vulgaris]. , 1967, Geka chiryo. Surgical therapy.